Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, Central Italy

Cancer Epidemiology

Volumn 34, Issue 2, 2010, Pages 162-167

  Ripabelli, Giancarlo ^a   Grasso, Guido M ^a   Del Riccio, Ilenia ^a   Tamburro, Manuela ^a   Sammarco, Michela L ^a  

^a UNIVERSITY OF MOLISE   (Italy)

Author keywords

Age groups; Human papillomavirus; Prevalence; Risk factors

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENE IDENTIFICATION; GENOTYPE; GROUPS BY AGE; HUMAN; HUMAN PAPILLOMA VIRUS 53; HUMAN PAPILLOMA VIRUS 66; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; SMOKING; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS TYPING; WART VIRUS; ADOLESCENT; EARLY DIAGNOSIS; GENETICS; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PARITY; PATHOLOGY; PREGNANCY; RISK FACTOR; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CERVIX UTERI; EARLY DETECTION OF CANCER; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARITY; PREGNANCY; PREVALENCE; RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77950299009     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.12.010     Document Type: Article

References (42)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
2. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., and Wacholder S. Human papillomavirus and cervical cancer. Lancet 370 (2007) 890-907
3. Trottier H., and Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 24 Suppl. 1 (2006) S1-15
4. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 (2007) 453-459
5. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 Suppl. 10 (2008) K1-16
6. Munoz N., Bosch F.X., de S.S., Herrero R., Castellsagué X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
7. Wheeler C.M. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol 4 April (2007) 224-235
8. World Health Organization (WHO). International Agency for Research on Cancer (IARC). Human papillomavirus. IARC monographs on the evaluation of carcinogenic risk to humans, vol. 90. International Agency for Research on Cancer; 2007.
9. Chan P.K., Luk A.C., Luk T.N., Lee K.F., Cheung J.L., Ho K.M., et al. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol 44 (2009) 111-114
10. Goodman M.T., Shvetsov Y.B., McDuffie K., Wilkens L.R., Zhu X., Thompson P.J., et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 68 (2008) 8813-8824
11. Agarossi A., Ferrazzi E., Parazzini F., Perno C.F., and Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 81 (2009) 529-535
12. Carozzi F., Bisanzi S., Sani C., Zappa M., Cecchini S., Ciatto S., et al. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease. J Clin Microbiol 45 (2007) 364-369
13. Martinelli D., Chironna M., Tafuri S., Neve A., Caputi G., Prato Ret al. Epidemiologia delle infezioni da HPV e del cervicocarcinoma in Puglia: studi ad hoc e analisi dei dati correnti (Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis). Ann Ig 19 (2007) 499-508
14. Menzo S., Ciavattini A., Bagnarelli P., Marinelli K., Sisti S., and Clementi M. Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types. BMC Microbiol 8 (2008) 112
15. Broccolo F., Chiari S., Piana A., Castiglia P., Dell'Anna T., Garcia-Parra R., et al. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy. J Med Virol 81 (2009) 278-287
16. Centurioni M.G., Puppo A., Merlo D.F., Pasciucco G., Cusimano E.R., Sirito R., et al. Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis 5 (2005) 77
17. De Francesco M.A., Gargiulo F., Schreiber C., Ciravolo G., Salinaro F., and Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol 75 (2005) 588-592
18. Verteramo R., Pierangeli A., Calzolari E., Patella A., Recine N., Mancini E., et al. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect 8 (2006) 2517-2521
19. Ammatuna P., Giovannelli L., Matranga D., Ciriminna S., and Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 17 (2008) 2002-2006
20. Del Prete R., Di Taranto A.M., Lipsi M.R., Nirchio V., Antonetti R., and Miragliotta G. Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol 42 (2008) 211-214
21. Kjaer S.K., Breugelmans G., Munk C., Junge J., Watson M., and Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV vaccination program in Denmark. Int J Cancer 123 (2008) 1864-1870
22. Pannier-Stockman C., Segard C., Bennamar S., Gondry J., Boulanger J.C., Sevestre H., et al. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol 42 (2008) 353-360
23. Hibbitts S., Jones J., Powell N., Dallimore N., McRea J., Beer H., et al. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer 99 (2008) 1929-1933
24. Bardin A., Vaccarella S., Clifford G.M., Lissowska J., Rekosz M., Bobkiewicz P., et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer 44 (2008) 557-564
25. Snijders P.J., van den Brule A.J., and Meijer C.J. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 201 1 (2003) 1-6
26. Burchell A.N., Winer R.L., de Sanjosé S., and Franco E.L. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 24 Suppl. 3 (2006) S3/52-S/10
27. Smith J.S., Melendy A., Rana R.K., and Pimenta J.M. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 43 4 Suppl. (2008) S5-25, S25.e1-41
28. Kovács K., Varnai A.D., Bollmann M., Bankfalvi A., Szendy M., Speich N., et al. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J Med Virol 80 (2008) 1814-1823
29. Dal Bello B.D., Spinillo A., Alberizzi P., Cesari S., Gardella B., D'Ambrosio G., et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 81 (2009) 703-712
30. Hamlin-Douglas L.K., Coutlée F., Roger M., Franco E.L., and Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev 17 (2008) 3141-3149
31. Mejlhede N., Bonde J., and Fomsgaard A. High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 117 (2009) 108-114
32. Ragin C.C., Watt A., Markovic N., Bunker C.H., Edwards R.P., Eckstein S., et al. Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer 4 Suppl. 1 (2009) S9
33. Simen-Kapeu A., La Ruche G., Kataja V., et al. Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control 20 (2009) 163-170
34. Watt A., Garwood D., Jackson M.N., Ragin C., Smikle M., et al. High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women. Infect Agent Cancer 4 Suppl. 1 (2009) S11
35. Werden J., Schnatz P.F., Mandavilli S., Allen G., Murphy J.L., Greene J.F., et al. Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests. J Low Genit Tract Dis 12 (2008) 287-292
36. Cotton S.C., Sharp L., Seth R., Masson L.F., Little J., Cruickshank M.E., et al. Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer 97 (2007) 133-139
37. Vaccarella S., Herrero R., Dai M., Snijders P.J., Meijer C.J., Thomas J.O., et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 15 (2006) 2148-2153
38. Green J., Berrington de Gonzalez A., Smith J.S., Franceschi S., Appleby P., Plummer M., et al. Human papillomavirus infection and use of oral contraceptives. Br J Cancer 88 (2003) 1713-1720
39. Beby-Defaux A., Bourgoin A., Ragot S., Battandier D., Lemasson J.M., Renaud O., et al. Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security. J Med Virol 73 (2004) 262-268
40. Rousseau M.C., Abrahamowicz M., Villa L.L., Costa M.C., Rohan T.E., and Franco E.L. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 12 (2003) 1029-1037
41. Muñoz N., Castellsagué X., de González A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl. 3 (2006) S3/1-S/10
42. Clifford G., Franceschi S., Diaz M., Muñoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S3/26-S/10